E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 13, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 368
- +62 vs. Q4 2023
- Portfolio value
- $1.61B
- +$36.4M (+2.3%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TTDTrade Desk, Inc. | Stock | 3,723 | $325.5K | <0.1% | −118−3.1% | Reduced | History |
| PTGXProtagonist Therapeutics, Inc | COM | 11,304 | $327.0K | <0.1% | +2,347+26.2% | Added | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 4,871 | $330.0K | <0.1% | −141−2.8% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 4,823 | $330.3K | <0.1% | +216+4.7% | Added | History |
| BKRBaker Hughes Co | CL A | 9,886 | $331.2K | <0.1% | −133−1.3% | Reduced | History |
| IBRXImmunityBio, Inc. | COM | 61,922 | $332.5K | <0.1% | +22,428+56.8% | Added | History |
| VRSKVerisk Analytics, Inc. | COM | 1,413 | $333.1K | <0.1% | −31−2.1% | Reduced | History |
| INBXInhibrx Biosciences, Inc. | COM | 9,544 | $333.7K | <0.1% | +4,032+73.1% | Added | History |
| BMEABiomea Fusion, Inc. | COM | 22,605 | $337.9K | <0.1% | +22,605 | New | History |
| VRDNViridian Therapeutics, Inc. | COM | 19,323 | $338.3K | <0.1% | +8,448+77.7% | Added | History |
| CVSCVS Health Corp | Stock | 4,255 | $339.4K | <0.1% | +597+16.3% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 18,488 | $341.8K | <0.1% | −4,405−19.2% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 6,350 | $344.4K | <0.1% | +731+13.0% | Added | History |
| EAElectronic Arts Inc. | COM | 2,604 | $345.5K | <0.1% | −43−1.6% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 18,544 | $347.5K | <0.1% | +2,062+12.5% | Added | History |
| CICigna Group | Stock | 959 | $348.3K | <0.1% | +6+0.6% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 13,899 | $351.1K | <0.1% | −10,273−42.5% | Reduced | History |
| PRTAProthena Corp Public Ltd Co | SHS | 14,340 | $355.2K | <0.1% | +3,244+29.2% | Added | History |
| VERAVera Therapeutics, Inc. | CL A | 8,260 | $356.2K | <0.1% | +8,260 | New | History |
| MDTMedtronic plc | Stock | 4,124 | $359.4K | <0.1% | +507+14.0% | Added | History |
| SYKStryker Corp | Stock | 1,014 | $362.9K | <0.1% | +57+6.0% | Added | History |
| ARDXArdelyx, Inc. | COM | 49,868 | $364.0K | <0.1% | −23,717−32.2% | Reduced | History |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 23,003 | $366.7K | <0.1% | +4,090+21.6% | Added | History |
| MORFMorphic Holding, Inc. | COM | 10,434 | $367.3K | <0.1% | −454−4.2% | Reduced | History |
| EXCExelon Corp | Stock | 9,831 | $369.4K | <0.1% | −82−0.8% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 713 | $369.7K | <0.1% | +93+15.0% | Added | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 12,956 | $370.5K | <0.1% | −6,575−33.7% | Reduced | History |
| KROSKeros Therapeutics, Inc. | COM | 5,648 | $373.9K | <0.1% | +5,648 | New | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 5,491 | $374.3K | <0.1% | −3,969−42.0% | Reduced | History |
| PHMPultegroup Inc | COM | 3,104 | $374.4K | <0.1% | +3,104 | New | History |
| TELTE Connectivity plc | REG SHS | 2,581 | $374.9K | <0.1% | −41−1.6% | Reduced | History |
| GERNGeron Corp | COM | 113,941 | $376.0K | <0.1% | +24,308+27.1% | Added | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 74,180 | $376.8K | <0.1% | +22,863+44.6% | Added | History |
| WBWEIBO Corp | SPONSORED ADR | 41,516 | $377.4K | <0.1% | −267,620−86.6% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 9,046 | $379.7K | <0.1% | +1,097+13.8% | Added | History |
| NVAXNovavax Inc | COM NEW | 79,514 | $380.1K | <0.1% | −7,044−8.1% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 11,547 | $381.5K | <0.1% | −6,627−36.5% | Reduced | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 38,866 | $385.2K | <0.1% | +38,866 | New | History |
| NUVLNuvalent, Inc. | COM | 5,136 | $385.7K | <0.1% | −1,662−24.4% | Reduced | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 38,727 | $386.1K | <0.1% | −15,367−28.4% | Reduced | History |
| CSGPCostar Group, Inc. | COM | 4,019 | $388.2K | <0.1% | −48−1.2% | Reduced | History |
| CHTRCharter Communications, Inc. | CL A | 1,351 | $392.6K | <0.1% | −58−4.1% | Reduced | History |
| TGTXTG Therapeutics, Inc. | COM | 25,826 | $392.8K | <0.1% | −4,727−15.5% | Reduced | History |
| ILMNIllumina, Inc. | COM | 2,875 | $394.8K | <0.1% | −17−0.6% | Reduced | History |
| TWSTTwist Bioscience Corp | COM | 11,535 | $395.8K | <0.1% | −748−6.1% | Reduced | History |
| FANGDiamondback Energy, Inc. | Stock | 2,006 | $397.5K | <0.1% | +223+12.5% | Added | History |
| NTLAIntellia Therapeutics, Inc. | COM | 14,460 | $397.8K | <0.1% | −2,091−12.6% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 8,577 | $400.5K | <0.1% | −3,294−27.7% | Reduced | History |
| KYMRKymera Therapeutics, Inc. | COM | 9,965 | $400.6K | <0.1% | +9,965 | New | History |
| ALKSAlkermes plc. | SHS | 14,816 | $401.1K | <0.1% | −3,757−20.2% | Reduced | History |
| LVMH Moet Hennessy Louis Vuitt502441306 | COM | 2,224 | $402.6K | <0.1% | +2,224 | New | – |
| KDPKeurig Dr Pepper Inc. | COM | 13,145 | $403.2K | <0.1% | −249−1.9% | Reduced | History |
| PTCTPTC Therapeutics, Inc. | COM | 13,908 | $404.6K | <0.1% | −4,280−23.5% | Reduced | History |
| PVHPVH Corp. | COM | 2,888 | $406.1K | <0.1% | +2,888 | New | History |
| PCVXVaxcyte, Inc. | COM | 5,962 | $407.3K | <0.1% | −2,514−29.7% | Reduced | History |
| BHVNBiohaven Ltd. | COM | 7,476 | $408.9K | <0.1% | −7,052−48.5% | Reduced | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 27,602 | $409.1K | <0.1% | −39,136−58.6% | Reduced | History |
| DVAXDynavax Technologies Corp | COM NEW | 32,980 | $409.3K | <0.1% | +3,964+13.7% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 1,783 | $409.6K | <0.1% | −205−10.3% | Reduced | History |
| SMCISuper Micro Computer, Inc. | COM | 406 | $410.1K | <0.1% | +406 | New | History |
| ITGartner Inc | COM | 862 | $410.9K | <0.1% | −15−1.7% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 7,032 | $413.3K | <0.1% | −625−8.2% | Reduced | History |
| FOLDAmicus Therapeutics, Inc. | COM | 35,232 | $415.0K | <0.1% | −7,316−17.2% | Reduced | History |
| ACLXArcellx, Inc. | COMMON STOCK | 5,986 | $416.3K | <0.1% | −26−0.4% | Reduced | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 9,512 | $417.4K | <0.1% | −873−8.4% | Reduced | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 8,486 | $417.7K | <0.1% | +734+9.5% | Added | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 15,549 | $418.9K | <0.1% | +4,352+38.9% | Added | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 48,097 | $418.9K | <0.1% | +10,410+27.6% | Added | History |
| KHCKraft Heinz Co | Stock | 11,353 | $418.9K | <0.1% | −280−2.4% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 17,638 | $419.8K | <0.1% | −3,942−18.3% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 2,814 | $420.6K | <0.1% | −526−15.7% | Reduced | History |
| DNLIDenali Therapeutics Inc. | COM | 20,552 | $421.7K | <0.1% | +3,262+18.9% | Added | History |
| HALOHalozyme Therapeutics, Inc. | COM | 10,385 | $422.5K | <0.1% | −1,638−13.6% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 15,577 | $422.6K | <0.1% | −1,601−9.3% | Reduced | History |
| VCELVericel Corp | COM | 8,145 | $423.7K | <0.1% | +2,462+43.3% | Added | History |
| ALTAltimmune, Inc. | COM NEW | 41,709 | $424.6K | <0.1% | +41,709 | New | History |
| IONSIonis Pharmaceuticals Inc | COM | 9,825 | $425.9K | <0.1% | −40−0.4% | Reduced | History |
| ROIVRoivant Sciences Ltd. | SHS | 40,576 | $427.7K | <0.1% | −8,284−17.0% | Reduced | History |
| Hermes Intl Sca ADR42751Q105 | ADR | 1,672 | $428.7K | <0.1% | +1,672 | New | – |
| PAYXPaychex Inc | Stock | 3,495 | $429.2K | <0.1% | −53−1.5% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 3,113 | $429.3K | <0.1% | −983−24.0% | Reduced | History |
| VRTVertiv Holdings Co | COM CL A | 5,267 | $430.2K | <0.1% | +5,267 | New | History |
| RVMDRevolution Medicines, Inc. | COM | 13,438 | $433.1K | <0.1% | −6,094−31.2% | Reduced | History |
| DASHDoorDash, Inc. | Stock | 3,152 | $434.1K | <0.1% | −39−1.2% | Reduced | History |
| FASTFastenal Co | Stock | 5,632 | $434.5K | <0.1% | −58−1.0% | Reduced | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 11,087 | $439.5K | <0.1% | +11,087 | New | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 5,042 | $440.4K | <0.1% | −126−2.4% | Reduced | History |
| CCLCarnival Corp Ltd. | UNIT 99/99/9999 | 27,038 | $441.8K | <0.1% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 13,675 | $441.8K | <0.1% | +1,419+11.6% | Added | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 10,506 | $444.1K | <0.1% | +2,907+38.3% | Added | History |
| NTRANatera, Inc. | COM | 4,866 | $445.0K | <0.1% | −3,394−41.1% | Reduced | History |
| BPMCBlueprint Medicines Corp | COM | 4,695 | $445.4K | <0.1% | −1,798−27.7% | Reduced | History |
| AEPAmerican Electric Power Co Inc | Stock | 5,181 | $446.1K | <0.1% | −45−0.9% | Reduced | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 10,333 | $447.7K | <0.1% | +3,800+58.2% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 2,522 | $448.7K | <0.1% | −1,973−43.9% | Reduced | History |
| CPCanadian Pacific Kansas City Ltd | COM | 5,099 | $449.6K | <0.1% | +5,099 | New | History |
| SRPTSarepta Therapeutics, Inc. | COM | 3,485 | $451.2K | <0.1% | −2,034−36.9% | Reduced | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 1,698 | $453.4K | <0.1% | −608−26.4% | Reduced | History |
| BBIOBridgeBio Pharma, Inc. | COM | 14,711 | $454.9K | <0.1% | −58−0.4% | Reduced | History |
| ODFLOld Dominion Freight Line, Inc. | COM | 2,084 | $457.0K | <0.1% | −34−1.6% | ReducedConverted for a 2-for-1 split | History |
Sold out since Q4 2023 (19)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| HSAIHesai Group | SPONSORED ADS | 170,914 | $1.52M | 0.1% | History |
| DQDaqo New Energy Corp. | SPNSRD ADS NEW | 50,735 | $1.35M | 0.1% | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 28,589 | $1.17M | 0.1% | History |
| NTESNetEase, Inc. | SPONSORED ADS | 11,365 | $1.06M | 0.1% | History |
| FUTUFutu Holdings Ltd | SPON ADS CL A | 18,944 | $1.03M | 0.1% | History |
| KRTXKaruna Therapeutics, Inc. | COM | 2,338 | $740.0K | <0.1% | History |
| RLXRLX Technology Inc. | SPONSORED ADS | 352,589 | $705.2K | <0.1% | History |
| BIDUBaidu, Inc. | ADR | 4,578 | $545.2K | <0.1% | History |
| MRTXMirati Therapeutics, Inc. | COM | 8,503 | $499.6K | <0.1% | History |
| IMGNImmunoGen, Inc. | COM | 16,443 | $487.5K | <0.1% | History |
| UUnity Software Inc. | COM | 9,211 | $376.6K | <0.1% | History |
| POOLPool Corp | COM | 907 | $361.6K | <0.1% | History |
| BABAAlibaba Group Holding Ltd | ADR | 4,488 | $347.9K | <0.1% | History |
| WBAWalgreens Boots Alliance, Inc. | COM | 8,549 | $223.2K | <0.1% | History |
| SPLKSplunk Inc | COM | 1,450 | $220.9K | <0.1% | History |
| BABoeing Co | Stock | 768 | $200.2K | <0.1% | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 12,618 | $184.2K | <0.1% | History |
| QUREuniQure N.V. | SHS | 19,687 | $133.3K | <0.1% | History |
| BLUEbluebird bio, Inc. | COM | 70,054 | $96.7K | <0.1% | History |